Literature DB >> 3131280

A possible role of glucocorticoids: an intrinsic inhibitor of the cytotoxic activity of tumor necrosis factor.

S Abe1, T Yamamoto, S Iihara, M Yamazaki, D Mizuno.   

Abstract

The cytotoxic activity of tumor necrosis factor (TNF) against L929 fibroblasts in vivo was noncompetitively inhibited by physiological concentrations of glucocorticoids such as hydrocortisone (10(-7) M), corticosterone (5 X 10(-8) M) and dexamethasone (5 X 10(-9) M). The inhibition was abolished by the addition of actinomycin D (0.5 microgram/ml) or cycloheximide (4 microM). A phospholipase A2 inhibitor, quinacrine (2 X 10(-6) M), also inhibited the TNF cytotoxicity. These findings suggest that the antitumor cytotoxic reaction by TNF is regulated by glucocorticoid through some mechanism involving de novo transcription and translation and that this regulatory mechanism may involve inhibition of phospholipase A2 activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131280      PMCID: PMC5917485          DOI: 10.1111/j.1349-7006.1988.tb01591.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

2.  Anti-tumour therapy by induction of endogenous tumour necrosis factor.

Authors:  M Kato; R Kakehi; G I Soma; T Gatanaga; D Mizuno
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

3.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

4.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

5.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

6.  Activation of membrane phospholipase A by guinea pig lymphotoxin (GLT).

Authors:  Y Kobayashi; J I Sawada; T Osawa
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

7.  Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.

Authors:  K Haranaka; N Satomi; A Sakurai
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

8.  Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.

Authors:  A Asher; J J Mulé; C M Reichert; E Shiloni; S A Rosenberg
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

9.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor.

Authors:  T Shirai; H Yamaguchi; H Ito; C W Todd; R B Wallace
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

10.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

View more
  2 in total

1.  Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation.

Authors:  R S Ames; B Holskin; M Mitcho; D Shalloway; M J Chen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  Inhibitory effects of inhaled flunisolide on inflammatory functions of alveolar macrophages.

Authors:  B Bewig; J Barth
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.